There was a rapid reduction of inflammation in patients who received Gepon inhalation. Bronchitis, laryngitis and sinusitis persisted for about 8 days in the Control Group B, while all 12 patients had recovered in Gepon Group B after 5 to 6 days. Thirty eight patients suffered acute viral ...